Pharma Mirror

JUNE 12, 2021

As growing strain on pharmaceutical technology necessitates more efficient practice, Alfa Laval has launched the CultureOne™, the industry’s first premium separator system for single-use cell culture processing. According to Bioplan Associates, single-use bioprocessing technologies now dominate the pre-commercial manufacturing space. However, Alfa Laval states many companies have not been able to make the transition to ‘full-single-use’ when harvesting proteins due to the lack of a single-use di

Manufacturing 130

Manufacturing Protein 130

Drug Patent Watch

JUNE 12, 2021

Annual Drug Patent Expirations for ZONTIVITY Zontivity is a drug marketed by Xspire Pharma and is included in one NDA. It is available from one supplier. There are three patents…. The post New patent expiration for Xspire Pharma drug ZONTIVITY appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 86

Drugs Marketing 86

Scienmag

JUNE 12, 2021

Credit: Image created by CA Ferreira et al., University of Wisconsin-Madison, Madison, WI. Reston, VA (Embargoed until 4:30 p.m. EDT, Saturday, June 12, 2021)–Positron emission tomography (PET) using a 68Ga-labeled fibroblast activation protein inhibitor (FAPI) can noninvasively identify and monitor pulmonary fibrosis, according to research presented at the Society of Nuclear Medicine and Molecular Imaging […].

Protein 52

Protein Medicine Research 52

Drug Patent Watch

JUNE 12, 2021

Annual Drug Patent Expirations for INTELENCE Intelence is a drug marketed by Janssen R And D and is included in one NDA. It is available from one supplier. There is…. The post New patent expiration for Janssen R drug INTELENCE appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 84

Drugs Marketing 84

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Clinical Research

BioTech 365

JUNE 12, 2021

Westlake Hills TX Dental Bonding Cosmetic Dentistry Updated Westlake Hills TX Dental Bonding Cosmetic Dentistry Updated Westlake Hills Dental Arts has updated cosmetic dental bonding treatents.

Cosmetics 52

Cosmetics 52

Clinical Trial Gurus

JUNE 12, 2021

In clinical research trials, protocol amendments are a very frequent occurrence. In this video I break down what cascade of events should occur from a regulatory and site training perspective whenever a new protocol amendment takes place.

Clinical Research 52

Clinical Research Research Trials 52

BioTech 365

JUNE 12, 2021

Core One Labs’ Biosynthesized Psilocybin Provisional Patent Imminent Core One Labs’ Biosynthesized Psilocybin Provisional Patent Imminent VANCOUVER, British Columbia, June 12, 2021 (GLOBE NEWSWIRE) — Core One Labs Inc.

40

40

Drug Patent Watch

JUNE 12, 2021

This chart shows the drugs with the most patents in Chile. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…. The post Which pharmaceutical drugs have the most drug patents in Chile? appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 98

Drugs 98

BioTech 365

JUNE 12, 2021

Incyte Announces Updated Data for Ruxolitinib Cream Accepted for Presentation at the 2021 Revolutionizing Atopic Dermatitis (RAD) Virtual Conference Incyte Announces Updated Data for Ruxolitinib Cream Accepted for Presentation at the 2021 Revolutionizing Atopic Dermatitis (RAD) Virtual Conference — First … Continue reading →

52

52

NY Times

JUNE 12, 2021

With the pandemic easing, the federal agency’s long-term agenda for drug approvals or new issues is languishing without a permanent commissioner.

Drugs 55

Drugs 55

Advertisement

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

Clinical Trials

BioTech 365

JUNE 12, 2021

Celltrion Healthcare presents the first real-world data for Truxima® (biosimilar rituximab) in patients with diffuse large B-cell lymphoma at the EHA 2021 Virtual Congress Celltrion Healthcare presents the first real-world data for Truxima® (biosimilar rituximab) in patients with diffuse large … Continue reading →

52

52

BioTech 365

JUNE 12, 2021

Longer-term Data for Kite’s Yescarta® in Relapsed or Refractory Follicular Lymphoma Demonstrate Substantial Survival Improvement Over Current Therapies in Comparative Analysis Longer-term Data for Kite’s Yescarta® in Relapsed or Refractory Follicular Lymphoma Demonstrate Substantial Survival Improvement Over Current Therapies in … Continue reading →

52

52

BioTech 365

JUNE 12, 2021

New Phase 3 Study Results Show IMBRUVICA® (ibrutinib)-Based Combination Regimen as an All-Oral Fixed-Duration Treatment Demonstrated Superior Progression-Free Survival in Adult Patients with Previously Untreated Chronic Lymphocytic Leukaemia New Phase 3 Study Results Show IMBRUVICA® (ibrutinib)-Based Combination Regimen as an … Continue reading →

52

52

BioTech 365

JUNE 12, 2021

Janssen Announces Results from Phase 3 MAIA Study Showing Significant Overall Survival Benefits for Treatment with DARZALEX®?

52

52

Advertisement

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

Clinical Supply